[go: up one dir, main page]

CA2209098A1 - Systeme de transduction de genes - Google Patents

Systeme de transduction de genes

Info

Publication number
CA2209098A1
CA2209098A1 CA 2209098 CA2209098A CA2209098A1 CA 2209098 A1 CA2209098 A1 CA 2209098A1 CA 2209098 CA2209098 CA 2209098 CA 2209098 A CA2209098 A CA 2209098A CA 2209098 A1 CA2209098 A1 CA 2209098A1
Authority
CA
Canada
Prior art keywords
gene
cells
virus
viral
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2209098
Other languages
English (en)
Inventor
David S. Strayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2209098A1 publication Critical patent/CA2209098A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/22043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un système de transduction de gènes qui utilise un virus SV40 à réplication déficiente et un gène étranger sélectionné. L'invention concerne également des procédés de préparation et d'utilisation du système de transduction de gènes.
CA 2209098 1994-12-30 1995-12-29 Systeme de transduction de genes Abandoned CA2209098A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36700294A 1994-12-30 1994-12-30
US08/367,002 1994-12-30

Publications (1)

Publication Number Publication Date
CA2209098A1 true CA2209098A1 (fr) 1996-07-11

Family

ID=23445534

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2209098 Abandoned CA2209098A1 (fr) 1994-12-30 1995-12-29 Systeme de transduction de genes

Country Status (4)

Country Link
EP (1) EP0801526A4 (fr)
AU (1) AU4649396A (fr)
CA (1) CA2209098A1 (fr)
WO (1) WO1996020598A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044348A1 (fr) * 1996-05-17 1997-11-27 Thomas Jefferson University Remplacement de genes a mediation par ribozymes
US5863794A (en) * 1997-01-08 1999-01-26 Thomas Jefferson University SV40 viral vectors for targeted integration into cells
WO1999027123A2 (fr) * 1997-11-26 1999-06-03 Board Of Regents, The University Of Texas System Vecteurs viraux sv40 modifies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
IL109558A (en) * 1994-05-04 2004-08-31 Yissum Res Dev Co DNA structures Derived from the SV40 virus that include DNA sequences External

Also Published As

Publication number Publication date
AU4649396A (en) 1996-07-24
EP0801526A1 (fr) 1997-10-22
WO1996020598A1 (fr) 1996-07-11
EP0801526A4 (fr) 1999-12-01

Similar Documents

Publication Publication Date Title
CA2229631C (fr) Therapie genique utilisant des vecteurs d'adenovirus ovins
JPH08503855A (ja) 嚢胞性線維症に対する遺伝子治療
US20010012516A1 (en) Viral vectors
JPH10503476A (ja) ＤＮＡ損傷剤およびр５３を含有する組成物
JP2001504325A (ja) 回帰的配列シャフリングおよび選択による遺伝子治療の最適化のための方法
JPH11510053A (ja) ヘルパーウイルス−フリーヘルペスウイルスベクターパッケージングシステム
JP2007511216A (ja) 変異ウイルス
KR20250068794A (ko) 게놈 편집을 위한 ｃｒｉｓｐｒ-ｃａｓ 시스템 및 조성물의 전달, 용도 및 치료적 응용
JP2003265193A (ja) 組換えｐ５３アデノウイルス
US7052904B2 (en) Hybrid adeno-retroviral vector for the transfection of cells
WO1995026411A2 (fr) Composition et methodes d'obtention de cellules productrices de virus de recombinaison isogeniques
US6806080B2 (en) Hybrid vectors for gene therapy
JPH08506722A (ja) 腫瘍を治療するためのレトロウイルスベクターおよびそれらを含む細胞系統
CN115803441A (zh) 用于恢复pah基因功能的腺相关病毒组合物和其使用方法
WO1996039036A1 (fr) Procedes et composition de creation de cellules syngeniques productrices de virus recombines
WO1996039036A9 (fr) Procedes et composition de creation de cellules syngeniques productrices de virus recombines
US6610287B1 (en) Transfer and expression of gene sequences into nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
US20020051767A1 (en) Cancer treatment
WO1995010623A1 (fr) Transfert selectif adenoviral de genes vers les cellules neointimales vasculaires
WO2007087462A9 (fr) Méthodes et compositions destinées au traitement du cancer, dans lesquelles est utilisé un nouvel adénovirus
CA2209098A1 (fr) Systeme de transduction de genes
JPH10509879A (ja) 複製欠陥ベクターを用いる、組織特異的処置、診断方法、および組成物
Sato et al. Nonviral gene transfer to surface skin of mid‐gestational murine embryos by intraamniotic injection and subsequent electroporation
US5863794A (en) SV40 viral vectors for targeted integration into cells
US20020164782A1 (en) Adenovirus vectors for gene therapy

Legal Events

Date Code Title Description
FZDE Dead